Finance

Lists
PHE:FRA
Cipher Pharmaceuticals Inc
€8.40
-3.45%
(-0.30) 1D
Aug 17, 8:02:24 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHE...
Open
€8.40
High
€8.40
Low
€8.40
Mkt. cap
356.86M
Avg. vol.
0.00
Volume
0.00
52-wk high
€12.20
52-wk low
€7.00
No. of employees
43
Open
€8.40
High
€8.40
Low
€8.40
Mkt. cap
356.86M
Avg. vol.
0.00
Volume
0.00
52-wk high
€12.20
52-wk low
€7.00
No. of employees
43
About Cipher Pharmaceuticals Inc
CEO-
Employees43
Founded2000
HeadquartersMississauga, Ontario, Canada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
12.83M
12.22M
12.50M
12.07M
Cost of goods sold
2.35M
2.30M
2.21M
2.37M
Cost of revenue
2.35M
2.30M
2.21M
2.37M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.71M
3.68M
2.90M
3.44M
Operating expense
5.51M
5.49M
4.70M
5.22M
Total operating expenses
7.86M
7.79M
6.91M
7.59M
Operating income
4.97M
4.43M
5.60M
4.48M
Other non operating income
-
-
-
15.00K
EBT including unusual items
4.26M
4.61M
4.95M
3.64M
EBT excluding unusual items
4.13M
4.84M
4.89M
3.64M
Income tax expense
-1.24M
-8.70M
-1.21M
-369.00K
Effective tax rate
-29.19%
-188.55%
-24.53%
-10.13%
Other operating expenses
-
-
-
-
Net income
5.50M
13.31M
6.16M
4.01M
Net profit margin
42.87%
108.95%
49.28%
33.26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-241.00K
-109.00K
-51.00K
-
Net interest expenses
-241.00K
-109.00K
-51.00K
-
Depreciation and amortization charges
1.80M
1.81M
1.81M
1.78M
EBITDA
6.77M
5.95M
7.32M
6.34M
Gain or loss from assets sale
-
-130.00K
-57.00K
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps